Published in Obesity and Diabetes Week, May 3rd, 2004
The company reported a net loss of $1,234,638, or $0.04 per share, for the quarter ended March 31, 2004, compared with a net loss of $834,158, or $0.04 per share, for the same period in 2003. Weighted-average common shares outstanding for the quarters ended March 31, 2004, and March 31, 2003, were 31.6 million and 22.6 million, respectively.
Total operating expenses were $1,241,166 and $907,651 for the quarters ended March 31, 2004 and 2003, respectively. The increase in operating expenses in the 2004 period was principally the result of higher stock...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week